Comparing Latuda vs Saphris
Latuda | Saphris |
|
---|
Latuda (lurasidone) | Saphris (asenapine) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Latuda is an atypical antipsychotic used for the treatment of schizophrenia and depression associated with Bipolar 1 disorder. Latuda should be taken with food (at least 350 calories). Prescribed for... View more |
Prescription only
Prescribed for Bipolar Disorder, Schizophrenia. Saphris may also be used for purposes not listed in this medication guide. |
Related suggestions Schizophrenia
|
|||||||||||||||
More about Latuda (lurasidone) | More about Saphris (asenapine) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Latuda has an average rating of 6.3 out of 10 from a total of 838 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 30% reported a negative effect. |
Saphris has an average rating of 7.4 out of 10 from a total of 315 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: Latuda side effects in more detail. |
See also: Saphris side effects in more detail. |
||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Latuda prices |
View all Saphris prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
Other asenapine brands include: Secuado | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
18 hours |
24 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 590 drugs are known to interact with Latuda:
|
A total of 641 drugs are known to interact with Saphris:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
October 28, 2010 |
August 13, 2009 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.